Chelbi-Alix M K, Boissard C, Rosselin G, Thang M N
I.N.S.E.R.M., Hôpital Saint-Antoine, Paris.
C R Acad Sci III. 1990;310(5):147-53.
Vasoactive Intestinal Peptide (VIP) is able at the concentration 10 to 100 nM to induce in HT-29 cells 2'5' oligoadenylate (2'5' A) synthetase activity. The kinetics of this induction show that the maximal effect is attained after 24 hrs. VIP induces 2'5' A synthetase parallel to inhibition of vesicular stomatitis virus growth. The levels of these two induced activities after VIP treatment are comparable to those induced by the poly (I).poly (C), an inducer of IFN beta/alpha in mammalian cells. Moreover the anti-IFN beta/alpha antibodies abolish the VIP-induced 2'5' A synthetase whereas anti-IFN gamma antibodies are ineffective. The fact that VIP establishes an antiviral state in HT-29 cells potentiates new pharmaceutical applications for this neuropeptide.
血管活性肠肽(VIP)在浓度为10至100 nM时能够诱导HT - 29细胞中的2',5'-寡腺苷酸(2'5'A)合成酶活性。这种诱导的动力学表明,最大效应在24小时后达到。VIP诱导2'5'A合成酶的同时抑制水泡性口炎病毒的生长。VIP处理后这两种诱导活性的水平与聚(I)·聚(C)(哺乳动物细胞中IFNβ/α的诱导剂)诱导的水平相当。此外,抗IFNβ/α抗体消除了VIP诱导的2'5'A合成酶,而抗IFNγ抗体则无效。VIP在HT - 29细胞中建立抗病毒状态这一事实增强了这种神经肽的新药物应用前景。